FDA Approves Leqembi for At-Home Maintenance Treatment of Alzheimer Disease

The US Food and Drug Administration (FDA) has approved Leqembi IQLIK (lecanemab), for self-administered injection for…

Eisai scores FDA nod for subcutaneous Leqembi maintenance dose

Aiming to deliver blockbuster sales of its Alzheimer’s-disease-fighting antibody Leqembi in its 2027 fiscal year, Eisai…